Author:
Ebbesen Finn,Madsen Poul H.,Rodrigo-Domingo Maria,Donneborg Mette L.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. American Academy of Pediatrics, Kemper et al. Clinical practical guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 150, e2022058959 (2022).
2. Pichon, J.-B., Riordan, S. M., Watchko, J. & Shapiro, S. The neurological sequelae of hyperbilirubinemia: definitions, diagnosis and treatment of the kernicterus spectrum disorders (KSDs). Curr. Pediatr. Rev. 13, 199–209 (2017).
3. Alken, J., Haakansson, S., Ekeus, C., Gustafson, P. & Norman, M. Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national for screening, diagnosis, and treatment in Sweden. JAMA Netw. Open 2, e190858 (2019).
4. Toenne, A., Meberg, A. & Hager, H. B. Erindring i diagnostik og behandling av hyperbilirubinemi hos nyfødte. Tidskr. Nor. Legeforen 130, 18–24 (2010).
5. Hansen, T. W. R. et al. Sixty years of phototherapy for neonatal jaundice: from serendipitous observation to standardized treatment and rescue for millions. J. Perinatol. 40, 180–193 (2020).